Las Vegas, NV -- (SBWIRE) -- 12/31/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Banro Corporation (USA)(NYSEMKT:BAA), Novavax, Inc.(NASDAQ:NVAX), Neuralstem, Inc. (NYSEMKT:CUR), Hovnanian Enterprises, Inc. (NYSE:HOV)
Banro Corporation (USA)(NYSEMKT:BAA) managed to keep its gain at 8.52% on above-normal volume of 2.15M shares. The stock settled at $0.553 after floating in a range of $0.50 to $0.56. Its latest price has reached market capitalization of $139.41 million. Its 52-week range has been $0.41 to $3.15. Banro Corporation (Banro) is a Canada-based gold exploration company. The Company holds, through four wholly owned subsidiaries, a 100% interest in four gold properties, which are known as Twangiza, Namoya, Lugushwa and Kamituga.
For How Long BAA will fight for Profitability? Read This Trend Analysis report
Novavax, Inc.(NASDAQ:NVAX) traded up on a volume of 3.96 million, lower than its standard daily volume. Shares have gained 0.58% to $5.16. Over the last twelve months, the stock has gained 173.02% and faced a worst price of $1.68. Novavax, Inc. (Novavax) is a clinical stage biopharmaceutical company. The Company focuses on developing recombinant vaccines. The Company’s technology platform is based on recombinant vaccine technology that includes the virus-like particles (VLPs).
For How Long NVAX’s Gloss will Attract Investors? Find out via this report
Neuralstem, Inc. (NYSEMKT:CUR) settled 9.70% higher at $2.94 on above-normal volume of 2.14M shares during the last trading day. The stock has its 12-month high at $3.02 and 52-week low price was $1. It traded in a range of $2.65 to $2.95 during the last trading day. Neuralstem, Inc. is a development-stage company focused on the development and commercialization of treatments for central nervous system disease based on transplanting human neural stems cells and the use of small molecule drugs.
Why Should Investors Buy CUR After the Recent Fall? Just Go Here and Find Out
In the last trading session, Hovnanian Enterprises, Inc. (NYSE:HOV) was up on low volume, trading at a volume of 3.60M shares versus its average daily volume of 4.35 million shares. At $6.44, the stock has attained market capitalization of $896.47 million. Hovnanian Enterprises, Inc. (Hovnanian) designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, mid-rise condominiums, urban infill and active adult homes in planned residential developments.
Will HOV Continue To Move Higher? Find Out Here
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)